A new jab that works even if the virus mutates and can spell the end of annual flu jabs for millions has been developed by scientists.
Researchers in Britain and Europe are poised to recruit thousands of people for large-scale trials which they hope will lead to widespread availability of the injection within five years, the Daily Express reported.
Bird Flu
Bird flu (avian influenza/avian flu) is a disease caused by an influenza virus (H5N1) that primarily affects birds but can infect humans also.
Advertisement
Professor John Oxford, Britain's leading expert on flu and the study's key researcher, said the vaccine has the potential to save thousands of lives a year.
Immunisation against flu viruses is difficult because they constantly evolve to develop resistance to vaccines.
However, according to Oxford, the aim of the universal jab is to protect people against all flu viruses even when they change.
The study was published by Public Health England and the London School of Hygiene and Tropical Medicine.
Source: ANI
However, according to Oxford, the aim of the universal jab is to protect people against all flu viruses even when they change.
The study was published by Public Health England and the London School of Hygiene and Tropical Medicine.
Source: ANI
Quiz on Flu
Influenza (or rather, the flu) is a cold weather infectious condition that affects the young and old alike. Though most reported cases are mild, the flu can sometimes cause severe and life-threatening complications in both children and adults, thanks to wrong medications and improper vaccinations. Learn more about the disease from our Flu Quiz and guard yourself and your family from a poss
Advertisement
 Using Smell to Detect Avian Influenza VirusThe way in which diseases can modify animal odors in subtle ways has been highlighted in new research. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial